Cercare Medical

At Cercare Medical, we are redefining neuroimaging with advanced software solutions that integrate seamlessly into clinical workflows. Leveraging state-of-the-art biomarkers, proprietary MRI and CT maps — such as oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2) — and cutting-edge AI, our software automates complex processes while offering an interface for manual verification, ensuring both efficiency and precision in clinical practice.

 

Built on our patented algorithm the Vascular Model, Cercare Medical Neurosuite (CMN) is fully automated and vendor-neutral software for the analysis of brain imaging data. It enables comprehensive assessments of neurological diseases involving vascular pathology across a variety of conditions, including Stroke, Oncology, Alzheimer’s, Dementia, and COVID-19.

 

Oxygenation and heterogeneity of blood flow are integral components of Cercare Medical’s proprietary biomarkers. These advanced features allow for more detailed assessments of tissue pathology, optimizing patient management for a wide range of indications.